Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly
Copyright policy )Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly
The fact that the number of people with Alzheimer’s disease is increasing, combined with the limited availability of drugs for its treatment, emphasize the need for the development of novel effective therapeutics for treating this brain disorder. Herein, we focus on generating 12 chalcone-donepezil hybrids, with the goal of simultaneously targeting amyloid-β (Aβ) peptides as well as cholinesterases (i.e., acetylcholinesterase (AChE) and butyrylcholinesterase (BChE)). We present the design, synthesis, and biochemical evaluation of these two series of novel 1,3-chalcone-donepezil (15a–15f) or 1,4-chalcone-donepezil (16a–16f) hybrids. We evaluate the relationship between their structures and their ability to inhibit AChE/BChE activity as well as their ability to bind Aβ peptides. We show that several of these novel chalcone-donepezil hybrids can successfully inhibit AChE/BChE as well as the assembly of N-biotinylated Aβ(1–42) oligomers. We also demonstrate that the Aβ binding site of these hybrids differs from that of Pittsburgh Compound B (PIB).
- University of Kentucky United States
Models, Molecular, aβ assembly, Aβ dissociation, Organic chemistry, Tritium, Article, aβ dissociation, QD241-441, Chalcones, Humans, Donepezil, Aβ assembly, <sup>3</sup>h-pib binding, Amyloid beta-Peptides, Aniline Compounds, alzheimer’s disease, 3H-PIB binding, acetylcholinesterase, Thiazoles, Butyrylcholinesterase, butyrylcholinesterase, Acetylcholinesterase, Cholinesterase Inhibitors, Alzheimer’s disease
Models, Molecular, aβ assembly, Aβ dissociation, Organic chemistry, Tritium, Article, aβ dissociation, QD241-441, Chalcones, Humans, Donepezil, Aβ assembly, <sup>3</sup>h-pib binding, Amyloid beta-Peptides, Aniline Compounds, alzheimer’s disease, 3H-PIB binding, acetylcholinesterase, Thiazoles, Butyrylcholinesterase, butyrylcholinesterase, Acetylcholinesterase, Cholinesterase Inhibitors, Alzheimer’s disease
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).10 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!